Minerva Neurosciences | NERV - Current Assets

Minerva Neurosciences reported $40.16M in Current Assets for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Current Assets Change
Acadia Pharmaceuticals ACAD:US USD 507.94M 13.62M
Adma Biologics ADMA:US USD 224.1M 1.32M
ALKERMES ALKS:US USD 1.26B 208.12M
AstraZeneca AZN:LN USD 22.59B 2.37B
Dynavax Technologies DVAX:US USD 916.98M 15.96M
Esperion Therapeutics ESPR:US USD 246.68M 15.1M
GlaxoSmithKline GSK:LN GBP 20.77B 520M
Halozyme Therapeutics HALO:US USD 739.01M 85.81M
IONIS PHARMACEUT IONS:US USD 2.2B 50.57M
Marinus Pharmaceuticals MRNS:US USD 252.38M 75.37M
Minerva Neurosciences NERV:US USD 40.16M 4.68M
Neurocrine Biosciences NBIX:US USD 1.45B 248M
Novartis NOVN:VX USD 36.91B 44M
Novavax NVAX:US USD 1.7B 56.57M
Roche Holding ROG:VX 33.82B 3.5B
Takeda 4502:JP JPY 2.6T 149.67B
Vanda Pharmaceuticals VNDA:US USD 519.29M 12.19M